Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Tumor Necrosis Factor-alpha »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tumor Necrosis Factor alpha-Induced Protein 3 < Tumor Necrosis Factor-alpha < Tumor Necrosis Factors  Facettes :

List of bibliographic references indexed by Tumor Necrosis Factor-alpha

Number of relevant bibliographic references: 313.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000634 (2019) Ariane Klein [Allemagne][Biologics in the treatment of juvenile idiopathic arthritis : A comparison of mono- and combination therapy with synthetic DMARDs].
000930 (2019) Durga Prasanna Misra [Inde] ; Anupam Wakhlu [Inde] ; Vikas Agarwal [Inde] ; Debashish Danda [Inde]Recent advances in the management of Takayasu arteritis.
000976 (2019) Yannick Degboé [France] ; Benjamin Rauwel [France] ; Michel Baron [France] ; Jean-Frédéric Boyer [France] ; Adeline Ruyssen-Witrand [France] ; Arnaud Constantin [France] ; Jean-Luc Davignon [France]Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
000C79 (2019) Andrea Rubbert-Roth [Suisse] ; Melinda Zsuzsanna Szab [Hongrie] ; Melinda Kedves [Hongrie] ; György Nagy [Hongrie] ; Fabiola Atzeni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents.
000C93 (2019) Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France]Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses
000D17 (2019) Samah Hamdy Elmedany [Égypte] ; Aly Elsayed Mohamed [Égypte] ; Sahar Mahfouz Abdel Galil [Égypte]Efficacy and safety profile of intravenous tocilizumab versus intravenous abatacept in treating female Saudi Arabian patients with active moderate-to-severe rheumatoid arthritis.
000D47 (2019) Izumi Kurata [Japon] ; Hiroto Tsuboi [Japon] ; Mayu Terasaki [Japon] ; Masaru Shimizu [Japon] ; Hirofumi Toko [Japon] ; Fumika Honda [Japon] ; Ayako Ohyama [Japon] ; Mizuki Yagishita [Japon] ; Atsumu Osada [Japon] ; Hiroshi Ebe [Japon] ; Hoshimi Kawaguchi [Japon] ; Hiroyuki Takahashi [Japon] ; Shinya Hagiwara [Japon] ; Hiromitsu Asashima [Japon] ; Yuya Kondo [Japon] ; Isao Matsumoto [Japon] ; Takayuki Sumida [Japon]Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
000D57 (2019) Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Deshire Alpizar-Rodriguez [Suisse] ; Catalin Codreanu [Italie] ; Florenzo Iannone [Italie] ; Eirik K. Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Maria J. Santos ; Cem Gabay [Suisse] ; Axel Finckh [Suisse] ; Delphine S. Courvoisier [Suisse]Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution.
000E20 (2019) Héctor Corominas ; Cayetano Alegre ; Javier Narváez [Espagne] ; Carlos Marras Fernández-Cid ; Vicenç Torrente-Segarra ; Manuel Rodríguez G Mez ; Francisco Maceiras Pan ; Rosa María Morlà ; Fernando José Rodríguez Martínez ; Antoni G Mez-Centeno [Espagne] ; Laura Losada Ares ; Rocío González Molina ; Silvia Paredes González-Albo ; Joan Dalmau-Carolà ; Carolina Pérez-García [Espagne] ; Ceferino Barbazán Álvarez ; Liliana Ercole [Espagne] ; Maria Ngeles Terrancle [Espagne]Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab
000E37 (2019) Yoshiki Nagai [Japon] ; Naoto Yokogawa [Japon] ; Kota Shimada [Japon] ; Shoji Sugii [Japon]Comparison of the clinical characteristics and severity of community-acquired pneumonia between patients with rheumatoid arthritis treated with tocilizumab and those treated with TNF inhibitor.
000E47 (2019) Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
000E93 (2019) Ruchika Goel [Inde] ; T. Sathish Kumar [Inde] ; Debashish Danda [Inde]Childhood-Onset Takayasu Arteritis (c-TA): Current and Future Drug Therapy.
000E96 (2019) Che-Mai Chang [Taïwan] ; Yu-Wen Hsu [Taïwan] ; Henry Sung-Ching Wong [Taïwan] ; James Cheng-Chung Wei [Taïwan] ; Xiao Liu [États-Unis] ; Hsien-Tzung Liao [Taïwan] ; Wei-Chiao Chang [Taïwan]Characterization of T-Cell Receptor Repertoire in Patients with Rheumatoid Arthritis Receiving Biologic Therapies
000F31 (2019) Dae Hyun Yoo [Corée du Sud]Biologics for the treatment of adult-onset still's disease.
001075 (2018) E. Diwo [France] ; P. Sève [France] ; S. Trad [France] ; P. Bielefeld [France] ; D. Sène [France] ; S. Abad [France] ; A. Brézin [France] ; P. Quartier [France] ; I. Koné Paut [France] ; M. Weber [France] ; C. Chiquet [France] ; M H Errera [France] ; J. Sellam [France] ; P. Cacoub [France] ; G. Kaplanski [France] ; L. Kodjikian [France] ; B. Bodaghi [France] ; D. Saadoun [France][Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
001085 (2018) A. Pierrot [France] ; C. Combe [France] ; M. Lepelley [France] ; M. Brucker [France] ; E. Constant [France][Berger's disease associated to an adalimumab-treated rheumatoid arthritis].
001099 (2018) Francesco Muratore [Italie] ; Giulia Pazzola [Italie] ; Alessandra Soriano [Italie] ; Nicol Pipitone [Italie] ; Stefania Croci [Italie] ; Martina Bonacini [Italie] ; Luigi Boiardi [Italie] ; Carlo Salvarani [Italie]Unmet Needs in the Pathogenesis and Treatment of Vasculitides.
001136 (2018) Mathilde Leclercq [France] ; M. Le Besnerais [France] ; V. Langlois [France] ; N. Girszyn [France] ; Y. Benhamou [France] ; C. Ngo [France] ; H. Levesque [France] ; M. Muraine [France] ; J. Gueudry [France]Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.
001138 (2018) Hilal Eser Ozturk [Turquie] ; Merih Oray [Turquie] ; Ilknur Tugal-Tutkun [Turquie]Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.
001150 (2018) Maria Gerosa [Italie] ; Lorenza Maria Argolini [Italie] ; Carolina Artusi [Italie] ; Cecilia Beatrice Chighizola [Italie]The use of biologics and small molecules in pregnant patients with rheumatic diseases.
001179 (2018) Erin Murray ; Alexandra Ellis ; Yekaterina Butylkova ; Martha Skup [États-Unis] ; Jasmina Kalabic [Allemagne] ; Vishvas Garg [États-Unis]Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Tumor Necrosis Factor-alpha" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Tumor Necrosis Factor-alpha" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Tumor Necrosis Factor-alpha
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021